1. Home
  2. CELU vs CPSH Comparison

CELU vs CPSH Comparison

Compare CELU & CPSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • CPSH
  • Stock Information
  • Founded
  • CELU 2016
  • CPSH 1984
  • Country
  • CELU United States
  • CPSH United States
  • Employees
  • CELU N/A
  • CPSH N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • CPSH Building Materials
  • Sector
  • CELU Health Care
  • CPSH Consumer Discretionary
  • Exchange
  • CELU Nasdaq
  • CPSH Nasdaq
  • Market Cap
  • CELU 42.2M
  • CPSH 40.7M
  • IPO Year
  • CELU N/A
  • CPSH 1987
  • Fundamental
  • Price
  • CELU $3.03
  • CPSH $2.55
  • Analyst Decision
  • CELU
  • CPSH
  • Analyst Count
  • CELU 0
  • CPSH 0
  • Target Price
  • CELU N/A
  • CPSH N/A
  • AVG Volume (30 Days)
  • CELU 491.2K
  • CPSH 98.1K
  • Earning Date
  • CELU 05-08-2025
  • CPSH 07-30-2025
  • Dividend Yield
  • CELU N/A
  • CPSH N/A
  • EPS Growth
  • CELU N/A
  • CPSH N/A
  • EPS
  • CELU N/A
  • CPSH N/A
  • Revenue
  • CELU $54,220,000.00
  • CPSH $22,716,633.00
  • Revenue This Year
  • CELU $23.29
  • CPSH N/A
  • Revenue Next Year
  • CELU N/A
  • CPSH N/A
  • P/E Ratio
  • CELU N/A
  • CPSH N/A
  • Revenue Growth
  • CELU 138.11
  • CPSH N/A
  • 52 Week Low
  • CELU $1.00
  • CPSH $1.27
  • 52 Week High
  • CELU $5.22
  • CPSH $3.18
  • Technical
  • Relative Strength Index (RSI)
  • CELU 71.05
  • CPSH 55.33
  • Support Level
  • CELU $2.01
  • CPSH $2.45
  • Resistance Level
  • CELU $2.66
  • CPSH $2.86
  • Average True Range (ATR)
  • CELU 0.24
  • CPSH 0.20
  • MACD
  • CELU 0.08
  • CPSH -0.02
  • Stochastic Oscillator
  • CELU 91.67
  • CPSH 80.00

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About CPSH CPS Technologies Corp.

CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.

Share on Social Networks: